Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SGX:T14
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SGX:T14
Price:
2.52
USD
0.4%
Market Closed
Market Cap:
$3.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SGX:T14
|
CN |
|
L
|
Lockheed Martin Corp
BMV:LMT
|
US |
|
N
|
NRG Energy Inc
XMUN:NRA
|
US |
|
Bankinter SA
OTC:BKIMF
|
ES |
|
International Paper Co
LSE:IPC
|
US |
|
M
|
Mitie Group PLC
F:MZ4
|
UK |
|
Hong Kong and China Gas Co Ltd
F:HCGS
|
HK |
|
A
|
Archrock Inc
SWB:54E
|
US |
|
R
|
Royal Bank of Canada
NYSE:RY
|
CA |
|
A
|
Allegro.eu SA
WSE:ALE
|
LU |
|
Former BL Stores Inc
OTC:BIGGQ
|
US |
|
Seven & i Holdings Co Ltd
TSE:3382
|
JP |
|
Darma Henwa Tbk PT
F:0DH
|
ID |
|
CAMP4 Therapeutics Corp
NASDAQ:CAMP
|
US |
|
C
|
Consensus Cloud Solutions Inc
NASDAQ:CCSI
|
US |
|
Getlink SE
PAR:GET
|
FR |
|
Henkel AG & Co KGaA
F:HEN
|
DE |
|
S
|
Sony Group Corp
XHAM:SON1
|
JP |
|
ZXZN Qi-House Holdings Ltd
HKEX:8395
|
HK |
|
M
|
Mastern Premier Reit 1
KRX:357430
|
KR |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is T14's stock price target?
Not Available
T14 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?
Projected CAGR
5%
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 3 years is 5%.
What is the Gross Profit forecast for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?
Projected CAGR
8%
8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next -9 years is 8%.
What is the Operating Income forecast for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?
Projected CAGR
78%
78%
Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 1 year is 78%.
What is the Pre-Tax Income forecast for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?
Projected CAGR
-15%
-15%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is -15%.
What is the Net Income forecast for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?
Projected CAGR
-15%
-15%
Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 3 years is -15%.